Albemarle Corporation (ALB) earnings on November 4, 2026

After the market closes Q3 2026

More Albemarle Corporation earnings

Prior outlook: Pessimistic Outcome: Missed

Albemarle shares closed 3.58% higher after quarterly results, even though the company maintained a sales outlook below analyst estimates.

ALB price around the earnings

98.37

Change: +3.6%

2026-11-05, 21:00 UTC

Start of the measured window End of the measured window
94.31 96.75 99.20 101.64 94.97
Price series around the eventClosing price per minute from before the event to the end of the measured window.No trading (market closed)
November 4, 2026 November 5, 2026
  • Price: green if it ends above the starting price; red if it ends below
  • Start of the measured window
  • End of the measured window
  • Market open
  • No trading (market closed)
  • Starting price
Price series around the event

Prior thesis

Prior outlook: Pessimistic Outcome: Missed

Thesis published
Results released

Weak price setup outweighs positive company news

The price setup is weak and outweighs the mildly positive news backdrop, so the outlook remains pessimistic. Analysts expect earnings growth, but the $155 price target is below the $192.64 last price and recent market review has underperformed the broader market.

Context analyzed before publication

Summary
Weak price setup outweighs positive company news
Playbook
ALB's price has fallen over the past two weeks and month while trailing SPY. Recent earnings results have exceeded estimates, and a $1.5 billion credit facility with the quarterly dividend provides support.
Trend
Recent evaluations improved, though the price remains weak

Analysts

Drivers

  • Analysts Neutral

    Most of 21 analyst opinions are favorable, but the $155 price target is below the $192.64 last price.

Evidence

Analyst consensus
Buy
Consensus average (1-5)
1.87
Analysts covering the stock
21
Average price target
154.68
Lowest price target
83.28
Highest price target
211
Upside to price target
63.8%
Quarterly earnings growth
1,996.2%
Revenue growth
31.1%
Forward EPS
10.44
Trailing EPS
0.27
Analyst moves in the last 60 days
8
  • Strong buy: 2
  • Buy: 12
  • Hold: 9
  • Sell: 0
  • Strong sell: 0
Strong buy
2
Buy
12
Hold
9
Sell
0
Strong sell
0
  • October 22, 2026 · Citigroup: Maintains rating (Buy → Buy)
  • October 20, 2026 · Truist Securities: Maintains rating (Buy → Buy)
  • October 15, 2026 · RBC Capital: Maintains rating (Outperform → Outperform)
  • October 14, 2026 · Mizuho: Upgrades rating (Neutral → Outperform)
  • October 13, 2026 · Barclays: Initiates coverage (Equal-Weight)
  • October 7, 2026 · Argus Research: Maintains rating (Buy → Buy)
  • October 5, 2026 · UBS: Maintains rating (Buy → Buy)
  • October 1, 2026 · Mizuho: Maintains rating (Neutral → Neutral)

News and sentiment

Drivers

  • News & sentiment Positive

    A $1.5 billion credit facility and a quarterly dividend support the company. Social media discussion is negative, which is consistent with the declining price.

Evidence

Sentiment
Sentiment
Cautious
Mention volume
High
Normalized volume
99%
Messages
30

Technicals

Drivers

  • Technical Negative

    ALB's price fell 5.81% over 14 days and 13.78% over 30 days while trailing SPY by 11.80%. The price data shows weak trend strength.

Evidence

Price when the context was analyzed
90.19
Average true range (ATR)
3.4%
Distance to 52-week high
-56.0%
14-day change (14d)
-5.8%
30-day change (32d)
-13.8%
30-day relative strength
-11.8%
SPY change (32d)
-2.0%
Nearest support
89.88
Distance to nearest support
0.4%
Nearest resistance
90.4
Distance to nearest resistance
0.2%
Volume accumulation ratio (14d / 46d)
1.07
  • Mid: 89.88 (0.4% away, 0.1 ATR, 15 touches)
  • Mid: 88.75 (1.6% away, 0.48 ATR, 13 touches)
  • Minor: 87.99 (2.4% away, 0.72 ATR, 9 touches)
  • Mid: 90.4 (0.2% away, 0.07 ATR, 15 touches)
  • Mid: 91.13 (1% away, 0.31 ATR, 20 touches)
  • Mid: 92.06 (2.1% away, 0.62 ATR, 14 touches)

Trends

Drivers

  • Macro & trends Negative

    ALB trailed SPY by 11.80 percentage points over 30 days, showing persistent underperformance.

Evidence

Average earnings surprise
+52.5%
  • August 5, 2026: actual EPS 3.75 vs estimate 3.24 (surprise +15.7%)
  • May 6, 2026: actual EPS 2.95 vs estimate 1.31 (surprise +124.6%)
  • February 11, 2026: actual EPS -0.53 vs estimate -0.49 (surprise -8.6%)
  • November 5, 2025: actual EPS -0.19 vs estimate -0.88 (surprise +78.3%)

Expected move

Drivers

  • Past earnings Positive

    Earnings per share exceeded estimates by 15.7% and 124.6% in recent reports. Three sessions after results opened higher, and two recent sessions closed higher, but the scenario points pessimistic.

Implied move
+5.8%
Source
Options chain

Reactions over its last 21 earnings

Median move
3%
75th percentile move
5.4%
90th percentile move
9.4%
Up / down moves
14 / 7
Average up move
+4.0%
Average down move
-5.1%

Monitoring and close

What Albemarle Corporation reported

Status
Finished
Actual EPS2.58
EPS estimate2.54
EPS surprise+1.6%
Revenue$1,553 million
Revenue estimate$1,517 million
Revenue surprise+2.4%

Albemarle's published third-quarter 2026 earnings call transcript contained no new details beyond previously reported results. The transcript attributed higher margins to lithium pricing and anticipated fourth-quarter headwinds.

Sources (12)

Pre-market second reading after the results

Verdict
Beat expectations

Heading into the open, Results beat expectations on both earnings and revenue and the price is indicating +1.9% pre-market, a move in line with the stock's usual reaction (about 3%). The figures don't confirm the prior scenario: the comparable cases aren't consistent enough.

How the stock reacted

Outcome
Missed
Consolidated
+3.6%
Max favorable move (MFE)
0%
Max adverse move (MAE)
7.7%